India, Nov. 10 -- Marksans Pharma announced that a current Good Manufacturing Practice (cGMP) inspection was conducted by the US FDA at the 2nd manufacturing facility of the Company located at Plot No. A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa, India from 3rd November 2025 to 7th November 2025.The said inspection concluded with Zero Form 483 observation.
Published by HT Digital Content Services with permission from Pivotal Sources....